<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

8 min read

SmartTRAK Insights from the 2024 AAOS/CG Musculoskeletal Conferences

By Elise Wolf on 3/15/24 9:30 AM

SmartTRAK experts across orthopedics, sports medicine, spine and enabling technology attended this year’s 2024 Canaccord Genuity Musculoskeletal and American Academy of Orthopedic Surgeons (AAOS) annual conferences. Held from February 12-15 in San Francisco, CA, these gatherings brought together the top minds in the industry. In this post, we share some key insights and updates gleaned from these conferences, offering a glimpse into the latest trends and innovations shaping the future of orthopedic and musculoskeletal care.

  • MARKET

Maxx Orthopedics*
SmartTRAK
learned at AAOS 2024 that Maxx Medical is going on the offensive to grow its joint replacement business in the US and that the Company plans to launch new hip and knee products in 2024.

Paragon 28*
At AAOS 2024, Paragon 28 noted that its supply chain issues have resolved and does not expect a headwind this year. As a result, Needham believes the company can return to ~20% revenue growth in 2024.

restor3d*
Restor3d reported it currently has 157 active distribution partners calling on ~22,965 orthopedic surgeons and ~18,000 podiatrists. Management noted surgeons will bring difficult cases and from there restor3d can create additional sales opportunities. CG 2024 Musculoskeletal Conference

  • REVENUES

BONESUPPORT*
BONESUPPORT highlighted the continued strength of Cerament G in North America with approximate revenues of $17.0MM in Q323 since launching in June 2023. CG 2024 Musculoskeletal Conference

OrthAlign*
At AAOS 2024, SmartTRAK learned that OrthAlign’s 2023 revenue was up +25% to $51MM, led by strong adoption of its Lantern next-generation handheld navigation system and increasing use of the Balance gap balancing feature on Lantern Knee. The company noted +37% growth in the ASC setting.

Find out how to receive SmartTRAK Daily Updates in your morning email

Continue Reading
2 min read

Total Joints Market 2024: Trends to Watch

By Lisa Mahan on 1/23/24 9:30 AM

Forces likely to influence the Total Joints Market in 2024

Final Q423 US Total Joints Market results are expected to solidify above pre-COVID growth rates for 2023. The post-pandemic patient backlog sustained strong market performance in 2023 despite tough comparisons and a challenging economic environment with rising inflation and the threat of a recession looming over healthcare consumers. What will the future hold? In this article, SmartTRAK looks at some of the trends to watch in 2024, including:

  • Mixed Predictions Regarding Patient Backlog
    Several Companies including Zimmer Biomet are banking on the backlog of patients to continue boosting procedure growth through 2024. Wall Street analysts, however, are more tempered in their forward-looking projections.
  • US Economic Factors Buoying Consumer Confidence
    The demand for health care is typically more resilient in the face of weaker economic conditions. However, improvements in some economic conditions in the US during 2024 are expected to buoy consumer confidence.
  • Ongoing Shift to Outpatient Site-of-Care Despite Reimbursement Decline
    Eligible patients are continuing to choose joint replacement surgery in an outpatient or ambulatory surgery center (ASC) setting in increasing numbers. New ASCs springing up around the country are giving potential patients expanded site-of-care options.
  • Ongoing Influence of ASC Economics
    ASCs facing lower reimbursement rates compared to hospital outpatient and inpatient settings will continue to look for product solutions that improve efficiency and reduce the overall cost of care.
  • New Product Launches to Watch
    New and early-stage hip and knee product launches for both large and mid-tier Joint Replacement Market players will drive revenue growth.

Just click the button below to download and read the complete "Total Joints 2024 Trends to Watch" market outlook article and analysis by Lisa Mahan, SmartTRAK's VP Product Development & IT, Sr. Analyst TJ&E. Read the Article
SmartTRAK
is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
Continue Reading
1 min read

Trends Potentially Impacting the Total Joints Market: A Flash Report

By Lisa Mahan on 10/18/23 8:03 AM

SmartTRAK takes a quick look at recent trends that may influence the Total Joints Market in the near and long term

Wall Street Analysts recently called out two trends specifically that could influence the Total Joints Market. One trend, the strengthening of the US dollar, is likely to impact the global market in 2024. Another trend is the increased prescribing of GLP-1 drugs, such as Ozempic, Wegovy, Byetta and Mounjaro, medications first used to treat Type 2 diabetes, as a treatment for obesity. This has the potential to impact the market down the road. In this downloadable article, SmartTRAK maps out the potential impact of these trends.

To download and read the complete article by SmartTRAK's Lisa Mahan, Product Development & IT, Sr. Analyst TJ&E, just click the button below. Read the Article

Continue Reading
2 min read

Favorable Winds of Change: Q123 Total Joints Market Recap

By Lisa Mahan on 6/8/23 9:30 AM

Increased elective procedure volume recovery lifts market growth to new heights

The winds of change precipitated a strong season of growth for the Total Joints Market. Company after company reported increasing elective procedural volume recovery due to the underlying post-COVID demand. Procedure momentum and easier year-over-year comparisons drove market growth above double-digits with the US Total Joints Market growing +14.5% in Q123. Easing of staffing headwinds and normalization of surgery cancellation rates were also contributing factors to accelerating procedures.
 

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Total Joints Market Recap* are:

  • Complete Q123 Total Joints Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Technologies and Procedure Recovery Elevating Hip Growth
  • The Ongoing March Towards Cementless Knees
  • Deals and Financing Highlights
  • Q123 Regulatory Highlights

Will this momentum continue throughout 2023? SmartTRAK believes underlying demand for hip and knee replacement surgery will ...

Read the entire Q123 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

AAOS 2023: Total Joint Viewpoint

By Lisa Mahan on 3/27/23 11:00 AM

AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement

If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including: 
  • Procedure Recovery May Signal Return of Deferred Procedures
    • Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...

  • The Move to Outpatient Joint Replacement Continues.
    • Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...

  • Cementless Knee Trend Growing Despite Mixed Results
    • Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...

  • Assistive Technologies Growing and Evolving
    • Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...

To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan,  VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. Download the AAOS 2023 Article

Continue Reading
2 min read

Strong Revenue Growth: Q422 Total Joints Market Highlights

By Lisa Mahan on 3/24/23 9:42 AM

Procedure recovery above Q4 seasonality, new products and assistive tech push strong revenue growth

  For Q422, the US Hip Replacement Market grew +8.4% according to SmartTRAK Financial Dashboard . Newer products, implant pull-through from assistive technologies and procedure recovery continued to positively impact growth. Nearly all companies in our reporting universe cited procedure recovery as a growth driver.
 
The US Knee Replacement Market grew +9.3% in Q422, driven in part by knee procedure recovery. Recovery appeared to be above that of the typical year-end seasonality of patients trying to fit in surgery before insurance deductibles reset. SmartTRAK has heard rumblings that the growth seen in Q4 may be a sign that ...
 

To read more about the strong revenue growth in the Total Joints Market, including Procedure Recovery, New Products and Assistive Technologies Driving Growth in the Hip Market and Cementless Knees and Enabling Tech Expanding the Knee Market, just click the link below.

 
* This link and the complete unedited article can only be viewed by SmartTRAK  subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please  click  the button below.Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

Total Joints Trends Heading Into 2023

By Lisa Mahan on 2/27/23 9:00 AM

SmartTRAK examines conditions lowering the flame for Total Joints

Procedural growth strengthened in 2022 giving rise to the hope that a backlog of patients created by the COVID pandemic would return to surgery, stoking the fires of Total Joint Market recovery. However, external market forces appear to be setting the market to simmer in 2023 while other forces influence the recipe for success for market players.
 
An analyst from JP Morgan has  drawn  parallels between the current behavior of the US stock and bond markets and the conditions leading up to the 1969 recession, according to a recent  Forbes  article. Interest rate hikes and high inflation have increased the likelihood that the US economy will face a recession in 2023. But what does that mean for the Total Joints Market?
 

Among the many topics covered in detail in this comprehensive article are:

Continue Reading
3 min read

Personalized Arthroplasty: The Future of Total Joint Surgery?

By Nick Fitzpatrick on 1/26/23 10:22 AM

SmartTRAK interviews Dr. Pascal-André Vendittoli to learn more about the Personalized Arthroplasty Society and this year’s annual meeting.

Dr. Vendittoli explains the difference between mechanical and kinematic alignment, what he looks for in total joint computer-assisted surgery systems and why he thinks personalized arthroplasty is the future of joint surgery. To find out more, listen to the SmartTRAK interview with Dr. Vendittoli in the video below (14:56 min). A link to download the transcript of the complete interview is also provided below.
Continue Reading
3 min read

The Future of PEKK in Orthopedics: An Interview w/ Oxford Performance Materials' Scott Felice

By Nick Fitzpatrick on 1/23/23 10:18 AM

SmartTRAK interviews Oxford Performance Materials CEO Scott DeFelice to learn more about the company’s PEKK-based materials solutions in orthopedics.

In an interview with   SmartTRAK, Oxford Performance Materials’ (OPM) CEO Scott DeFelice explains the history of his company, the difference between PEKK, PEEK and titanium-based implants and the Company’s future plans in the orthopedic space.

To find out more, including OPM’s plan to expand into the custom trauma market and its planned release of an all-polymer total knee, just click on the following video to listen to the full interview. (29:13 min).  A link to download a transcript of the complete interview is also provided below.

Continue Reading
2 min read

Economics and the Shift to ASCs: SmartTRAK at AAHKS 2022

By Lisa Mahan on 11/29/22 9:30 AM

Highlighting the economic conversation at AAHKS 2022 changing the landscape of joint replacement

At the American Association of Hip and Knee Surgeons (AAHKS) 2022 Annual Meeting in Dallas, SmartTRAK identified economics as a leading conversation theme under the guise of other topics. AAHKS 2022 itself was not immune to rising economic pressures as many clinicians were rumored to have backed out of attending the meeting and several exhibiting companies scaled down their participation as well. Surgeons not only attended sessions to enhance their clinical knowledge, but they also discussed facing the challenges of reduced reimbursement. In the exhibit hall, Companies featured products and technologies seemingly geared towards the shift of hip and knee replacement procedures to the more cost-conscious ambulatory surgery center (ASC) setting.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Economic Pressures
  • Reimbursement Challenges 
  • The Decline of CMS Physician Primary Hip Replacement Reimbursement
  • Manufacturers Targeting ASCs, including:
    • Smith& Nephew
    • ConFormMIS
    • Exactech
    • Maxx Medical
    • DePuy Synthes
Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles